Effect of retroperitoneal lymphadenectomy on prognosis of patients with epithelial ovarian cancer

Chinese Medical Journal

Volumn 116, Issue 4, 2003, Pages 588-592

  Wang, Zehua ^a   Xiong, Zhoufang ^a   Wang, Shixuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ovarian neoplasms; Prognosis; Retroperitoneal lymphadenectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GROUPS BY AGE; HUMAN; KAPLAN MEIER METHOD; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; OVARY CANCER; PARAAORTIC LYMPH NODE; PROGNOSIS; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SCHOOL CHILD; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; RETROPERITONEAL SPACE; SURVIVAL RATE;

EID: 0037606002     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Eisenkop SM, Friedman RL, Wang HJ, et al. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998;69:103-108.
2. Hogberg T, Carstensen J, Simonsen E, et al. Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. Gynecol Oncol 1993;48:38-49.
3. William J, William P, Mark F, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994; 170:974-980.
4. Zinzindohoue C, Lujan R, Boulet S, et al. Pelvic and para-aortic lymphadenectomy in epithelial ovarian cancer. Report of a series of 86 cases. Ann Chir 2000;125:163-172.
5. Allen DG, Planner RS, Grant PT. Maximum effort in the management of ovarian cancer, including pelvic and para-aortic lymphadenectomy. Aust N Z J Obstet Gynaecol 1992; 32:50-53.
6. Monga M, Carmicael JA, Shelley WE, et al. Surgery without adjuvant chemotherapy for early epithelial ovarian cancer after comprehensive surgical staging. Gynecol Oncol 1991;43: 195.
7. Jean L, Anne F, Jacques S, et al. Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 2000;78:21-27.
8. Di Re F and Baiocchi G. Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium. Int J Gynecol Cancer 2000;10:435-442.
9. Di Re F, Baiocchi G, Fontanelli R, et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol 1996;62:360-365.
10. Wu XH, Zhang ZY, Tang MQ, et al. A clinical study on the incidence of retroperitoneal lymph node metastasis and its risk factors in ovarian cancer. Zonghua Fu Chan Ke Za Zhi 1996; 31:543-547.